Neogen Corporation (NEOG) vs TransMedics Group, Inc. (TMDX)
Neogen Corporation and TransMedics Group, Inc. are both Medical Devices companies. Neogen Corporation and TransMedics Group, Inc. are of similar size ($3.0B and $2.9B). Neogen Corporation has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 19.3×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 25.8% against −2.72%. TransMedics Group, Inc. has the higher net margin (22.7% vs −0.91%) and the higher return on invested capital (5.62% vs −0.50%). Across the 20 metrics below, TransMedics Group, Inc. leads on 16 and Neogen Corporation on 4.
Valuation
Profitability
| Metric | NEOG | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.93% | 58.69% | 56.01% |
| Operating margin | (2.48%) | 12.21% | (15.03%) |
| Net margin | (0.91%) | 22.69% | (20.40%) |
| Free cash flow margin | 3.68% | 11.82% | (7.24%) |
| Return on equity | (0.38%) | 36.28% | (15.32%) |
| Return on assets | (0.23%) | 12.88% | (19.72%) |
| Return on invested capital | (0.50%) | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack